Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-22-001586
Filing Date
2022-02-14
Accepted
2022-02-14 16:13:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 d9177405_13g-a.htm SC 13G/A 130822
  Complete submission text file 0000919574-22-001586.txt   132604
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Subject) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80378 | Film No.: 22632014
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540
Business Address 731 ALEXANDER ROAD BUILDING 2, SUITE 500 PRINCETON NJ 08540 609-419-1800
CAXTON CORP (Filed by) CIK: 0001388551 (see all company filings)

EIN.: 222437619 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A